Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy

Part of paid clinical trials in Minneapolis, Minnesota.

Sponsor
Masonic Cancer Center, University of Minnesota
Study ID
NCT06414278
Status
Recruiting
Apply to this trial

Conditions

  • Hematopoietic and Lymphatic System Neoplasm
  • Malignant Solid Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

This clinical trial evaluates the use of a tool kit, Stress, Affect, Language and Speech Analysis (SALSA), for early identification of cognitive side effects of immunotherapy compared to the standard of care assessment.

Key Dates

Start date
Feb 8, 2024
Status verified
Jan 2026
Primary completion
Jul 21, 2027
Completion
Feb 21, 2028

Study Design

Enrollment
38 participants (estimated)

Arms

  • Arm: Observational
    Patients complete SALSA assessment and ICE assessments on study. Patients also have their medical records reviewed on study.

Primary Outcome Measure

Proportion of patients completing at least 80 percent of planned SALSA administrations during post CAR-T hospitalization [ Time Frame: 18 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Minnesota/Masonic Cancer CenterMinneapolisMinnesota55455
Veronika Bachanova
[email protected]
612-625-5469
Veronika Bachanova (PRINCIPAL_INVESTIGATOR)

Find similar trials in Minneapolis, MN

By research site
University of Minnesota/Masonic Cancer Center· Minneapolis, MN

Related Studies